ArticleEuropean radiology2026
Quantitative CT of emphysema, wall thickness and mucus plugs in alpha-1-antitrypsin deficiency: relationship to clinical outcomes.
Article in European radiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Identification of imaging-based pulmonary and extrapulmonary treatable traits in COPD: a review.Frontiers in medicine · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesAlpha-1-antitrypsin deficiency (AATD) is a rare genetic disorder leading to chronic obstructive pulmonary disease (COPD). Emphysema is the major structural damage visible on CT scans. However, there is little knowledge on the association between other structural abnormalities, such as bronchiectasis (BE), airway wall thickening (WT) or mucus plugs (MP), and clinical features. MATERIALS AND
methodsRetrospective study between 2008 and 2022 at one University Hospital of Bordeaux on all consecutive AATD patients. Bronchial and parenchymal alterations were evaluated with an (artificial intelligence) AI-driven Normalized Volume of Airway Abnormalities (NOVAA-CT) scoring system, including BE, WT, MP and emphysema quantifications. We evaluated correlations between forced expiratory volume in 1-s (FEV1%), dyspnea severity through the mMRC scale and the occurrence of at least one exacerbation in the year following CT scan.
resultsFifty-two AATD patients were included (median FEV1: 47% (40-65)). CT features of BE, WT and MP were present in 100%, 94.2% and 59% of the study population, respectively, with a lower versus upper lung predominance (p < 0.05). WT (p < 0.001) and BE (p = 0.04) correlated with FEV1% but not mMRC (p ≥ 0.09). Conversely, MP did not correlate with FEV1% (p = 0.08) but with mMRC (p = 0.01). Emphysema strongly correlated with both FEV1% and mMRC (p < 0.001). In multivariate analysis, after adjustment for age, genotype and tobacco consumption, the best predictor of exacerbation was WT (OR = 1.12 [1.02-1.22]; p = 0.01).
conclusionThis study demonstrates that AI-assisted identification of structural airway abnormalities is frequent in AATD patients and carries distinct clinical significance. Among them, WT was the most robust predictor of exacerbations. KEY POINTS: Question Emphysema is the major structural damage in alpha-1-antitrypsin deficiency (AATD). Clinical associations of bronchial abnormalities such as bronchiectasis (BE), mucus plugs (MP) and wall thickness (WT) are lacking. Findings Quantitative CT of BE and WT correlated with PFT (p ≤ 0.05), while MP correlated with dyspnea scale (p = 0.01). The best predictor of exacerbation was WT (OR = 1.12 [1.02-1.24]). Clinical relevance AI-assisted identification of bronchial abnormalities is frequent in AATD patients in addition to emphysema alone and carries distinct clinical significance. These findings highlight the importance of comprehensive CT-based evaluations to better characterize disease phenotype and guide clinical management in AATD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.